Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9171
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 7 $2,715 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,715 Current and potential, with all options
- Last date to order 11% complete
- IDV ceiling <1% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV SPE2DR25D9171 is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.
The IDC was awarded under the SPE2DB program and encompasses various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites. The IDC is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Azithromycin I.V. 500 MG vials | Defense Logistics Agency | $124 | |
| Midazolam HCL 25 MG/5 ML vial 5ML | Defense Logistics Agency | $217 | |
| Cyclophosphamide 500 MG vials | Defense Logistics Agency | $1,868 | |
| Water for injection vial 10ML | Defense Logistics Agency | $26 | |
| Silver sulfadiazine 1% cream 25GM | Defense Logistics Agency | $9 | |
| Forane liquid 250ML | Defense Logistics Agency | $317 | |
| Forane liquid 250ML | Defense Logistics Agency | $154 |
Quick answers
Who was awarded contract SPE2DR25D9171?
SPE2DR25D9171 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DR25D9171 worth?
Orders under SPE2DR25D9171 have obligated $2,715. SPE2DR25D9171's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9171?
7 orders have been placed under SPE2DR25D9171, the latest on June 16, 2026.
Who can order from contract SPE2DR25D9171?
SPE2DR25D9171 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9171 competed?
The extent of competition for SPE2DR25D9171 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV